Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

HCW Biologics (HCWB) Asset Utilization Ratio (2022 - 2025)

Historic Asset Utilization Ratio for HCW Biologics (HCWB) over the last 4 years, with Q3 2025 value amounting to 0.02.

  • HCW Biologics' Asset Utilization Ratio fell 8814.57% to 0.02 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.02, marking a year-over-year decrease of 8814.57%. This contributed to the annual value of 0.09 for FY2024, which is 1580.17% up from last year.
  • HCW Biologics' Asset Utilization Ratio amounted to 0.02 in Q3 2025, which was down 8814.57% from 0.03 recorded in Q2 2025.
  • Over the past 5 years, HCW Biologics' Asset Utilization Ratio peaked at 0.14 during Q2 2024, and registered a low of 0.02 during Q3 2025.
  • Moreover, its 4-year median value for Asset Utilization Ratio was 0.09 (2023), whereas its average is 0.09.
  • As far as peak fluctuations go, HCW Biologics' Asset Utilization Ratio soared by 7202.66% in 2024, and later tumbled by 8814.57% in 2025.
  • HCW Biologics' Asset Utilization Ratio (Quarter) stood at 0.14 in 2022, then crashed by 35.29% to 0.09 in 2023, then increased by 1.99% to 0.09 in 2024, then crashed by 82.82% to 0.02 in 2025.
  • Its last three reported values are 0.02 in Q3 2025, 0.03 for Q2 2025, and 0.05 during Q1 2025.